SC Filed 2019-02-12 Event — SEC 0001144204-19-006361 →

Sofinnova Venture Partners VIII, L.P. → Natera, Inc. NTRA

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

7 transactions

0 buys · 6 sales · 1 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 4.13

4,867,085 shares short · +47.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

2 holders · $29.28M

Duquesne Family OfficePoint72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-27	Brophy Michael Burkes	officer	Sale	771	$203.75	$157K
2026-04-27	Chapman Steven Leonard	director, officer	Sale	2,272	$203.75	$463K
2026-04-27	Fesko John	officer	Sale	771	$203.75	$157K
2026-04-27	Moshkevich Solomon	officer	Sale	997	$203.75	$203K
2026-04-27	RABINOWITZ DANIEL	officer	Sale	873	$203.75	$178K
2026-04-27	Sheena Jonathan	director	Sale	285	$203.75	$58K
2026-04-06	Rabinowitz Matthew	director, officer	Option exercise	58,292	$9.59	$559K

Other Filings by Sofinnova Venture Partners VIII, L.P.

Filed	Form	Issuer	Stake	Shares
2025-02-25	SCHEDULE	NuCana plc NCNA	10.00%	51,030	view →
2018-02-14	SC	Aclaris Therapeutics, Inc. ACRS	—	—	view →
2018-02-14	SC	SYNLOGIC, INC. SYBX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →